• Genskey secures RMB50m in series B+ financing

    Genskey announced that it has obtained RMB50 million in series B+ financing round joined by Fortune Capital and Legend Capital. The proceeds will be mainly used to develop a new generation of pathogen diagnostic products and clinical trials. The company has just completed a series B financing with millions of yuan at the end of 2019.